Sciascia R, Mazza P, Tondi L
Istituto di Radioterapia L. Galvani, Bologna.
Radiol Med. 1988 Jul-Aug;76(1-2):87-90.
A retrospective study was conducted on 14 patients with idiopathic myelofibrosis after splenic irradiation in order to cure the symptoms due to secondary splenomegaly. Radiation dose ranged from 700 to 2400 cGy, depending on both clinical response and hematological toxicity. Relief of symptoms was observed in all patients (100%); reduction of splenic size ranged from 30 to 70%, with more than 50% reduction in 13/16 cases. Side effects were mild neutropenia and thrombocytopenia, which did not require interruption of treatment; four patients registered a severe anemia. All the hematological side effects stopped with the suspension of treatment. This study shows the beneficial effect of radiation therapy on the symptoms connected to splenomegaly; however, the short duration of response suggests the advantage of splenic low-dose irradiation, to be periodically repeated.
为治疗特发性骨髓纤维化继发脾肿大所致症状,对14例接受脾区照射的患者进行了一项回顾性研究。照射剂量为700至2400 cGy,具体取决于临床反应和血液学毒性。所有患者(100%)症状均得到缓解;脾脏大小缩小30%至70%,16例中有13例缩小超过50%。副作用为轻度中性粒细胞减少和血小板减少,无需中断治疗;4例患者出现严重贫血。所有血液学副作用在治疗暂停后均停止。本研究显示了放射治疗对与脾肿大相关症状的有益作用;然而,反应持续时间较短表明脾区低剂量照射具有优势,可定期重复进行。